On May 11, 2022 Targovax ASA reported that members of its executive management team and key scientist are invited to present at upcoming conferences (Press release, Targovax, MAY 11, 2022, View Source [SID1234614188]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

33rd Annual Cancer Progress Conference, virtual
Panel: Victor Levitsky (CSO)
Panel title: Cancer Vaccines Redux: mRNA, Oncolytic Viruses, Or Good Old-Fashioned Peptides – Is It the Target(s), Immunization Platform, Clin Dev Strategy, or All of the Above?
Date: 11 May 2022
Time: 13:30 CET

Preclinical Immuno-Oncology, virtual
Presentation: Thomas B Hansen (VP Research)
Date: 18 May 2022
Time: 12:25 BST /13:25 CET

ABGSC Life Science Summit 2022, virtual
Presentation: Erik Digman Wiklund (CEO)
Date: 19 May 2022
Time: 10:30 CET

8th Annual Immuno-Oncology Innovation Forum, virtual
Panel: Lubor Gaal (CFO)
Panel title: Optimizing the Inherent Combination Value of Oncolytic Viruses Panel
Date: 25 May 2022
Time: 14:20 EDT / 20:20 CET

The presentations will be available on www.targovax.com after the conferences.